SCM
DNA icon

Sterling Capital Management’s Ginkgo Bioworks DNA Stock Holding History

Sterling Capital Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.51K Sell
960
-406
-30% -$3.4K ﹤0.01% 2247
2026
Q1 		$8.37K Sell
1,366
-879
-39% -$7.31K ﹤0.01% 2474
2025
Q4 		$18.7K Sell
2,245
-271
-11% -$2.92K ﹤0.01% 2265
2025
Q3 		$36.7K Buy
2,516
+1,528
+155% +$18.3K ﹤0.01% 1874
2025
Q2 		$11.1K Buy
+988
New +$7.65K ﹤0.01% 2059

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Sterling Capital Management's DNA Position: Q2 2026 in Review

Sterling Capital Management reduced its Ginkgo Bioworks (DNA) stake by 30% in Q2 2026, selling an estimated $3.4K and leaving 960 shares worth $9.51K. The position accounts for ﹤0.01% of the portfolio, ranked #2247.

Sterling Capital Management first reported a position in DNA in Q2 2025 and has held it in 5 quarters since. The position peaked at $36.7K in Q3 2025. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Sterling Capital Management held 960 shares of Ginkgo Bioworks worth $9.51K as of Q2 2026.
  • Sterling Capital Management sold 406 Ginkgo Bioworks shares in Q2 2026, an estimated $3.4K.
  • Ginkgo Bioworks made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2247 holding.
  • Sterling Capital Management first reported a position in Ginkgo Bioworks in Q2 2025 and has held it in 5 quarters since.
  • Sterling Capital Management's Ginkgo Bioworks position peaked at $36.7K in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.